Endologix reported the appointment of Dr. Matthew Thompson, as President. Dr. Thompson will also join Endologix's Board of Directors. Richard Mott, who previously held the CEO position on an interim basis, will return to his role as Executive Chairman of the Board of Directors. Dr. Thompson has been serving as Endologix's Chief Medical Officer since 2016, and, in that capacity, had oversight of the Company's business development, medical affairs, regulatory, clinical, and R&D departments.